Clinical Trials for TCR2 Therapeutics

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: TCR2 Therapeutics

Clinical Trials (2)

NCT05451849
A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer
PHASE1/PHASE2Active, not recruiting
6 participants
Started: Jun 21, 2022 · Completed: Oct 30, 2028
17 conditions1 sponsor7 locations
NCT03907852
Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer
PHASE1/PHASE2Active, not recruiting
57 participants
Started: Apr 15, 2019 · Completed: Nov 2, 2028
11 conditions2 sponsors11 locations